TechInvention is now a Biotech Ignition Grant 19 scheme awardee

The Mumbai based startup is developing new biologics for infectious diseases that are affordable in developing nations

0
111
New Delhi: TechInvention, a promising Indian start-up has been acknowledged and accredited by the Biotechnology Industry Research Assistance Council (BIRAC) through the Biotechnology Ignition Grant (BIG) 19 scheme.
The awardees received grant in the category of Drugs and Drug Delivery for their project titled “Development of Recombinant Lysins against Drug-Resistant E.coli”. 
“This grant is a huge honour. AMR’s rapid growth necessitates prompt intervention. It’s never been more critical to recognize the situation’s gravity and prepare for the looming pandemic. That’s why we at TechInvention are working on a platform technology that can enable the use of lysins as Enzybiotics against pathogens classified as Priority 1: Critical by the WHO for AMR,” said Syed Ahmed, the founder of TechInvention Lifecare.
Mumbai based TechInvention was one of the few organizations to make it to the finals of the National Startup Awards 2021. It was also part of the team that recently presented policy recommendations to the Prime Minister Narendra Modi on the theme “Nudging the DNA” as part of a DPIIT, Startup India, and Invest India’s programme-Startup Innovation Week.
The company is developing platform technologies dedicated to recombinant vaccines, lysins, and monoclonal antibodies, which focus on contagious diseases that primarily affect the developing world and are poised to play a critical role in pandemic preparedness and capacity building.
The company amongst other deals, has successfully enabled a tech transfer deal of Haemophilus influenza B vaccine technology to a middle-income country and Hepaitis B vaccine to a least developed country. 
Techinvention currently supports clinical trials of five different products from four other companies amongst which is direct deal with Eubiologics Co, South Korea, to bring EuvicholPlus, the first oral cholera vaccine (OCV), in a single-dose, low-density polyethylene package to India. Eubiologics has shipped more than 55 million doses to UN health authorities.
The company is a bootstrapped startup, it have been cash positive since year two of inception and fund all of their research and development projects from internal accruals. Techinvention is getting into a JV with a large manufacturing firm that will enable it to scale up its technology platforms from Research/Pilot scale to commercial scale to help it achieve its mission.